drugset
drugset / Trial / NCT02581397

Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive Cough

NCT02581397 ↗

Phase 3 Terminated 270 enrolled Ache Laboratorios Farmaceuticos S.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the non-inferiority of Suppository Transpulmin and Suppository Guaiacol compared to Transpulmin Syrup in the treatment of cough with secretion of infectious origin in children between two and six years old. One third of participants will receive Suppository Transpulmin, the other one third will receive Suppository Guaiacol and the last one third will receive Transpulmin Syrup.

Timeline

Start
2015-05-05
Primary completion
2016-12-06
Completion
2016-12-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Guaiacol Small molecule 1 unknown Rectal
Comparator Guaifenesin Small molecule 7.5 ml Oral
Subject Menthol Small molecule 1 unknown Rectal
Subject camphor Unknown 1 unknown Rectal
Subject eucalyptol Small molecule 1 unknown Rectal

Indications

No indication recorded.